Conditions for optimal Candida biofilm development in microtiter plates
- PMID: 19152039
- DOI: 10.1007/978-1-60327-151-6_7
Conditions for optimal Candida biofilm development in microtiter plates
Abstract
Development of Candida spp. biofilms on medical devices such as catheters and voice prosthesis has been recognized as an increasing clinical problem. Simple device removal is often impossible, while in addition, resulting candidal infections are difficult to resolve due to their increased resistance to many antifungal agents. Susceptibility studies of clinical isolates are generally performed according to the CLSI standard, which measures planktonic cell susceptibility, but similar standards have not been designed or applied to testing of cells growing within a biofilm. As consistent biofilms from many strains are more difficult to simultaneously obtain and analyze than are independent planktonic cultures, any standard assay must address these concerns. In the present chapter, optimized conditions that promote biofilm formation within individual wells of microtiter plates are described. In addition, the method has proven useful in preparing C. albicans biofilms for investigation by a variety of microscopic and molecular techniques.
Similar articles
-
Techniques for antifungal susceptibility testing of Candida albicans biofilms.Methods Mol Med. 2005;118:71-9. doi: 10.1385/1-59259-943-5:071. Methods Mol Med. 2005. PMID: 15888936
-
In Vitro Models for Candida Biofilm Development.Methods Mol Biol. 2016;1356:95-105. doi: 10.1007/978-1-4939-3052-4_8. Methods Mol Biol. 2016. PMID: 26519068
-
Synergistic activity of lysozyme and antifungal agents against Candida albicans biofilms on denture acrylic surfaces.Arch Oral Biol. 2009 Feb;54(2):115-26. doi: 10.1016/j.archoralbio.2008.09.015. Epub 2008 Nov 26. Arch Oral Biol. 2009. PMID: 19038377
-
Antifungal susceptibility of Candida albicans in biofilms.Mycoses. 2012 May;55(3):199-204. doi: 10.1111/j.1439-0507.2011.02076.x. Epub 2011 Jul 28. Mycoses. 2012. PMID: 21793943 Review.
-
Candida biofilms: antifungal resistance and emerging therapeutic options.Curr Opin Investig Drugs. 2004 Feb;5(2):186-97. Curr Opin Investig Drugs. 2004. PMID: 15043393 Review.
Cited by
-
The development and treatment of periprosthetic leakage after prosthetic voice restoration. A literature review and personal experience part I: the development of periprosthetic leakage.Eur Arch Otorhinolaryngol. 2015 Mar;272(3):641-59. doi: 10.1007/s00405-014-3394-7. Epub 2014 Nov 18. Eur Arch Otorhinolaryngol. 2015. PMID: 25404116 Review.
-
In vitro activity of micafungin against biofilms of Candida albicans, Candida glabrata, and Candida parapsilosis at different stages of maturation.Folia Microbiol (Praha). 2018 Mar;63(2):209-216. doi: 10.1007/s12223-017-0555-2. Epub 2017 Oct 5. Folia Microbiol (Praha). 2018. PMID: 28983822
-
Activity of Novel Ultrashort Cyclic Lipopeptides against Biofilm of Candida albicans Isolated from VVC in the Ex Vivo Animal Vaginal Model and BioFlux Biofilm Model-A Pilot Study.Int J Mol Sci. 2022 Nov 21;23(22):14453. doi: 10.3390/ijms232214453. Int J Mol Sci. 2022. PMID: 36430935 Free PMC article.
-
Antifungal Activity of Linear and Disulfide-Cyclized Ultrashort Cationic Lipopeptides Alone and in Combination with Fluconazole against Vulvovaginal Candida spp.Pharmaceutics. 2021 Sep 30;13(10):1589. doi: 10.3390/pharmaceutics13101589. Pharmaceutics. 2021. PMID: 34683882 Free PMC article.
-
A Selective Serotonin Reuptake Inhibitor, a Proton Pump Inhibitor, and Two Calcium Channel Blockers Inhibit Candida albicans Biofilms.Microorganisms. 2020 May 18;8(5):756. doi: 10.3390/microorganisms8050756. Microorganisms. 2020. PMID: 32443498 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous